Correlation Between DexCom and Xvivo Perfusion

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both DexCom and Xvivo Perfusion at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DexCom and Xvivo Perfusion into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DexCom Inc and Xvivo Perfusion AB, you can compare the effects of market volatilities on DexCom and Xvivo Perfusion and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DexCom with a short position of Xvivo Perfusion. Check out your portfolio center. Please also check ongoing floating volatility patterns of DexCom and Xvivo Perfusion.

Diversification Opportunities for DexCom and Xvivo Perfusion

-0.44
  Correlation Coefficient

Very good diversification

The 3 months correlation between DexCom and Xvivo is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding DexCom Inc and Xvivo Perfusion AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Xvivo Perfusion AB and DexCom is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DexCom Inc are associated (or correlated) with Xvivo Perfusion. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Xvivo Perfusion AB has no effect on the direction of DexCom i.e., DexCom and Xvivo Perfusion go up and down completely randomly.

Pair Corralation between DexCom and Xvivo Perfusion

Given the investment horizon of 90 days DexCom Inc is expected to generate 1.61 times more return on investment than Xvivo Perfusion. However, DexCom is 1.61 times more volatile than Xvivo Perfusion AB. It trades about 0.16 of its potential returns per unit of risk. Xvivo Perfusion AB is currently generating about -0.31 per unit of risk. If you would invest  7,210  in DexCom Inc on August 28, 2024 and sell it today you would earn a total of  573.00  from holding DexCom Inc or generate 7.95% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

DexCom Inc  vs.  Xvivo Perfusion AB

 Performance 
       Timeline  
DexCom Inc 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in DexCom Inc are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating fundamental indicators, DexCom may actually be approaching a critical reversion point that can send shares even higher in December 2024.
Xvivo Perfusion AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Xvivo Perfusion AB has generated negative risk-adjusted returns adding no value to investors with long positions. Despite abnormal performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

DexCom and Xvivo Perfusion Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with DexCom and Xvivo Perfusion

The main advantage of trading using opposite DexCom and Xvivo Perfusion positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DexCom position performs unexpectedly, Xvivo Perfusion can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Xvivo Perfusion will offset losses from the drop in Xvivo Perfusion's long position.
The idea behind DexCom Inc and Xvivo Perfusion AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.

Other Complementary Tools

Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators